Plasma and Urinary Soluble Thrombomodulin in Newborns with Respiratory Distress Syndrome and Chronic Lung Disease.
スポンサーリンク
概要
- 論文の詳細を見る
Thrombomodulin (TM), which is mainly present on the surface membrane of endothelial cells, plays an important role in the prevention of thrombosis. It is also present in a free form, named soluble TM (sTM), in circulating blood and urine. Plasma sTM has recently attracted considerable attention as a marker of protease damage to endothelium. We previously reported the plasma and urine levels of sTM in neonates, infants and children, and showed a good correlation between plasma and urinary sTM levels in healthy children. In this study, we investigated sTM levels in newborns with respiratory distress syndrome (RDS) and chronic lung disease (CLD). Plasma and urinary sTM levels in patients with RDS at birth were not significantly elevated as compared to those in healthy neonates. They were found to be remarkably higher in patients with CLD (plasma sTM 1-6 Ms : CLD ; 21.7 ± 7.2 TU/ml, nonCLD ; 14.9± 3.5 TU/ml <I>p</I>< 0.001, urinary sTM 1-6 Ms : CLD ; 280.3 ±126.3 TU/mgCr, nonCLD ; 132.8 ± 37.3 TU/mgCr <I>p</I>< 0.05). These data suggest that CLD in newborns may be evaluated with serial measurements of plasma and urinary sTM.
- 特定非営利活動法人 日本小児血液・がん学会の論文
特定非営利活動法人 日本小児血液・がん学会 | 論文
- The Parent's Emotional Adaptation to the Children's Malignant Disease
- Side Effect of Cranial Radiation in Childhood Acute Leukemia
- Red Blood Cell Volume Distribution Width in Normal Children and in the Patients with Various Kinds of Hematological Disorders.
- Effective Conditioning of Donors for Granulocyte Transfusions with Recombinant Human Granulocyte Colony-Stimulating Factor.
- Two Infant Girls of CNS Leukemia with Chronic Subdural Hematoma